Using targeted transcriptomic analysis and qPCR, we observed a significant increase in the expression of genes related to the AHR pathway (CYP1A1, CYP1B1, AHRR) in mouse OPCs and human neuroblastoma SH-SY5Y cells after treatment with EDA. The gene discussed is CYP1A1; the disease is neuroblastoma.